Cargando…
PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression
BACKGROUND: About 10–20% of patients with bladder cancer (BC) progress to muscle-invasive diseases, of which the underlying key molecular events have yet to be addressed. RESULTS: Here, we identified poly(A) binding protein nuclear 1 (PABPN1), a general factor of alternative polyadenylation (APA), w...
Autores principales: | Chen, Liang, Dong, Wei, Zhou, Menghao, Yang, Chenlu, Xiong, Ming, Kazobinka, Gallina, Chen, Zhaohui, Xing, Yifei, Hou, Teng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987104/ https://www.ncbi.nlm.nih.gov/pubmed/36879298 http://dx.doi.org/10.1186/s13578-023-00997-6 |
Ejemplares similares
-
NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation
por: Xiong, Ming, et al.
Publicado: (2019) -
Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer
por: Xiong, Ming, et al.
Publicado: (2022) -
circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis
por: Chen, Liang, et al.
Publicado: (2021) -
Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer
por: Ichinose, Junji, et al.
Publicado: (2014) -
An alanine expanded PABPN1 causes increased utilization of intronic polyadenylation sites
por: Abbassi-Daloii, Tooba, et al.
Publicado: (2017)